Bausch Health
221 hedge funds and large institutions have $1.18B invested in Bausch Health in 2026 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 70 increasing their positions, 63 reducing their positions, and 34 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 63
0.93% more ownership
Funds ownership: 62.53% → 63.46% (+0.93%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
3% less funds holding
Funds holding: 229 → 221 (-8)
7% less capital invested
Capital invested by funds: $1.27B → $1.18B (-$86.1M)
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
50% less call options, than puts
Call options by funds: $24M | Put options by funds: $48.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG Americas Securities
New York
|
+$29.6M |
| 2 |
D.E. Shaw & Co
New York
|
+$11.1M |
| 3 |
GJL
Gendell Jeffrey L
|
+$5.73M |
| 4 |
Goldman Sachs
New York
|
+$5.46M |
| 5 |
Man Group
London,
United Kingdom
|
+$4.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Nomura Holdings
Tokyo,
Japan
|
-$46.1M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$19.4M |
| 3 |
Walleye Capital
New York
|
-$6.32M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$4.3M |
| 5 |
BNP Paribas Asset Management
Paris,
France
|
-$3.69M |
BHC Hedge Fund Activity: Q2 2026 in Review
221 of the 8,349 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q2 2026, worth a combined $1.18B — down 6.8% from $1.27B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of BHC and 27 opened new positions — a net loss of 7 holders — while 63 trimmed existing stakes and 70 added.
The largest buyer was SG Americas Securities, adding an estimated $29.6M. The largest seller was Nomura Holdings, cutting an estimated $46.1M.
- 221 institutional investors held Bausch Health (BHC) as of Q2 2026, down from 229 in Q1 2026.
- Funds reported $1.18B of Bausch Health stock for Q2 2026, down 6.8% quarter-over-quarter.
- 27 funds opened new Bausch Health positions in Q2 2026 and 34 closed out, a net change of -7 holders.
- The largest Bausch Health buyer in Q2 2026 was SG Americas Securities, an estimated $29.6M added.
- The largest Bausch Health seller in Q2 2026 was Nomura Holdings, an estimated $46.1M sold.
Based on aggregated 13F filings for Q2 2026.